Podme logo
HjemOppdagKategorierSøk
Benefits & Risks of Peptide Therapeutics for Physical & Mental Health

Benefits & Risks of Peptide Therapeutics for Physical & Mental Health

01:26:412024-04-01

Om episode

In this episode, I explain the major categories and types of peptides currently in use for therapeutic purposes. I discuss peptides for improving tissue rejuvenation and repair, promoting longevity, improving muscle growth and fat loss, and boosting mood, vitality, and libido. I explain the biology of how these peptides work and both their potential benefits and risks. I also discuss peptide sourcing, dosages, cycling, routes of administration, and how peptides work in combination.  This episode will help you better understand the rapidly expanding landscape of peptide therapeutics and how to evaluate if specific peptides might be advantageous towards achieving your physical or mental health goals. For show notes, including referenced articles and additional resources, please visit hubermanlab.com. Use Ask Huberman Lab, our new AI-powered platform, for a summary, clips, and insights from this episode. Thank you to our sponsors AG1: }https://drinkag1.com/huberman Mateína: }https://drinkmateina.com/huberman Levels: }https://levels.link/huberman Joovv: }https://joovv.com/huberman LMNT: }https://drinklmnt.com/huberman Momentous: }https://livemomentous.com/huberman Timestamps (00:00:00) Peptides (00:03:20) Sponsors: Mateina, Levels & Joovv (00:07:44) What is a Peptide? (00:12:06) Peptide Sourcing, Lipopolysaccharide (LPS) (00:14:48) Rejuvenation & Tissue Repair: BPC-157, Angiogenesis (00:21:50) BPC-157 & Tissue Injury; Mode of Delivery (00:27:53) BPC-157: Safety, Doses, Cycling, Tumor Risk (00:35:16) Sponsor: AG1 (00:36:43) Tissue Repair: Thymosin Beta-4, TB-500 (00:40:49) Growth & Metabolism: Growth Hormone, IGF-1, Risks (00:45:25) Secretagogues, Sermorelin, Tesamorelin, CJC-1295 (00:52:21) Sponsor: LMNT (00:53:44) Ipamorelin, Hexarelin, GHRP-3, MK-677; Risks & Timing (00:58:69) Peptides for Growth Hormone & IGF-1, Risk; Combinations & Dosing (01:06:12) Longevity: Thymosin Beta-4, Epitalon (Epithalon) (01:12:09) Vitality: Melanotan, PT-141 (Vyleesi), Risks (01:17:21) Vitality: Kisspeptin (01:21:46) Peptides, Potential Benefits, Side-Effects & Risks (01:24:19) Zero-Cost Support, Spotify & Apple Reviews, Sponsors, YouTube Feedback, Momentous, Social Media, Neural Network Newsletter Disclaimer

Nyeste episoder

Huberman Lab
Huberman Lab

Dr. Diego Bohórquez: The Science of Your Gut Sense & the Gut-Brain Axis

2024-05-272h 42min
Huberman Lab
Huberman Lab

Dr. Gary Steinberg: How to Improve Brain Health & Offset Neurodegeneration

2024-05-201h 55min
Huberman Lab
Huberman Lab

LIVE EVENT Q&A: Dr. Andrew Huberman at the ICC Sydney Theatre

2024-05-1751min
Huberman Lab
Huberman Lab

Dr. James Hollis: How to Find Your True Purpose & Create Your Best Life

2024-05-132h 39min
Huberman Lab
Huberman Lab

GUEST SERIES | Dr. Matt Walker: The Science of Dreams, Nightmares & Lucid Dreaming

2024-05-082h 33min
Huberman Lab
Huberman Lab

Dr. Casey Means: Transform Your Health by Improving Metabolism, Hormone & Blood Sugar Regulation

2024-05-062h 56min
Huberman Lab
Huberman Lab

GUEST SERIES | Dr. Matt Walker: Improve Sleep to Boost Mood & Emotional Regulation

2024-05-012h 15min
Huberman Lab
Huberman Lab

AMA #17: Making Time for Fitness, Top Sleep Tools & Best Learning Strategies

2024-04-3025min
Huberman Lab
Huberman Lab

Protocols to Strengthen & Pain Proof Your Back

2024-04-292h 8min
Huberman Lab
Huberman Lab

GUEST SERIES | Dr. Matt Walker: Using Sleep to Improve Learning, Creativity & Memory

2024-04-242h 28min
logo

PODME

INFORMASJON

  • Om informasjonskapsler
  • Generelle vilkår
  • Personvernerklæring

LAST NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag
redaktorsansvar

Podme arbeider etter Vær Varsom-plakatens regler for god presseskikk. Ansvarlig redaktør og daglig leder er Kristin Ward Heimdal. Redaktør for eksterne innholdssamarbeid er Mathias Thaulow Lisberg.

© Podme AB 2024